tirzepatide triple agonist Semaglutide vs vs retatrutide: the complete three-way comparison Retatrutide vs Tirzepatide: What the
Description
Phase 3 tirzepatide trials show approximately 1622% body weight reduction

Beyond WL, these effects may be partly driven by its triple agonism, particularly glucagon receptor activation, which enhances lipid oxidation and reduces hepatic lipid synthesis [56]

And Prof Kamila Hawthorne, of the Royal College of GPs, warned the drug should not be seen as a "silver bullet", adding that it did not come without risk and would not be the right course of treatment for everyone who is eligible

It will be offered to people with a body mass index (BMI) of more than 35 and at least one obesity-related health problem - potentially 3.4 million people

Remember, Mounjaro is not a magic injection, it is an aid to be used in conjunction with exercise and improved nutrition
